Categories: BioTechDrugITLegalTechLocalTechnology
InCephalo is a preclinical stage biotech company founded in May 2021. InCephalo's six (6) founders with various backgrounds came together with the vision of making a difference in the lives of those being diagnosed with brain cancer. The founders experienced first-hand what it means if someone important to them gets diagnosed with this disease. The founding team has complementary competencies and consists of academics, a neurosurgeon, a legal expert, and a biotech entrepreneur. Since its foundation, the company convinced world-renown neurosurgeons, neuro-oncologists, preclinical, clinical, and regulatory experts to join them.
The company focuses on developing antibodies and other biological treatments for the local treatment of CNS cancers. Its primary drug candidate recieved EMA ODD.
Investors 2
Mentions in press and media 5
Reviews 0
